FDA Recall Open, Classified

REF TIN3015, 15G x 79 mm Bone Marrow Aspiration/Intraosseous Infusion Needle, For Single Use Only, Sterile EO, UDI: 10885403043796

Recall: Z-0002-2022 · Initiated July 27, 2021

Recall

Recall Number
Z-0002-2022
Event Number
88473
Firm
Bard Peripheral Vascular Inc
FEI Number
2020394
Product Code
FMI
Status
Open, Classified
Root Cause
Packaging change control
Initiated
July 27, 2021
Address
1625 W 3rd St, Bldg 1, Tempe, AZ, 85281-2438

Description

REF TIN3015, 15G x 79 mm Bone Marrow Aspiration/Intraosseous Infusion Needle, For Single Use Only, Sterile EO, UDI: 10885403043796

Reason

Potential for needle protector to become fully dislodge exposing infusion needle which could result in needle stick.

Action

On August 4, 2021, Bard Peripheral Vascular, Inc. issued an "Urgent Medical device Correction" notice to affected customers via Fed Ex. In addition to informing consignees about the recall product, BD ask consignees to take the following actions: 1. Please check all inventory locations within your institution for the product listed in Attachment A and immediately destroy all affected product remaining in your possession. The product should have the sterile barrier broken and destroyed per your local facility s destruction process. 2. Share this notice with any users of the product within your facilities to ensure they are also aware of this Urgent Medical Device Correction. 3. If you purchased this product from a distributor, contact your distributor for further instructions. 4. Complete and return the attached Customer Response Form to the BD contact noted on the form confirming acknowledgement of the correction notification, whether or not you have any affected product, so that BD may acknowledge your receipt of this notification and process your credit. 5. Please contact your BD representative to assist in this process or you may also contact the number below for further assistance. 6. Report any adverse health consequences experienced with the use of this product to BD. Events may also be reported to the FDA's MedWatch Adverse Event Reporting program: Web: MedWatch website at www.fda.gov/medwatch Phone: 1-800-FDA-1088 (1-800-332-1088) Mail: MedWatch, HF-2, FDA, 5600 Fisher s Lane, Rockville, MD 20852-9787 7. BD Contact Information: If you require further assistance please contact: North American Regional Complaint Center, 1-844-8BD- LIFE (1-844-823-5433) Say Recall when prompted, M-F 8am - 5pm CT, Recall Questions, Product Complaints, Technical Questions

Distribution

Worldwide distribution - US Nationwide distribution in the states of AL, AR, AZ, CA, CO, DE, FL, GA, IA, ID, IL, IN, KS, KY, LA, MA, MD, MI, MN, MO, NC, NE, NH, NJ, NY, OH, OK, OR, PA, PR, RI, SC, SD, TN, TX, UT, VA, WA, WV and the countries of Netherlands, United Arab Emirates, Australia, Taiwan, Asia, South Africa, Canada, JAPAN, India, Hong Kong, New Zealand, Mexico, China, Belgium, Malaysia, Singapore, Vietnam.